NovoCure NVCR
NASDAQ NVCR
$15.92 -0.03 (-0.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovoCure (NVCR) Non-Current Deferred Tax Liability (2018)

Updated

NovoCure (NVCR) posted Non-Current Deferred Tax Liability of $124,000 for Q4 2018.

Analysis

NovoCure (NVCR) Non-Current Deferred Tax Liability (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 NovoCure 1.86 Bn -496.48 Mn 142.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 124,000.00
API Access

NovoCure Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=NVCR&period=max&api_key=YOUR_API_KEY